| Michael Dennison Conroy, MD | |
|
16205 Baywood Ln, Granger, IN 46530-7896 | |
| (574) 271-0244 | |
| Not Available |
| Full Name | Michael Dennison Conroy |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 16205 Baywood Ln, Granger, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083822993 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01023561A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael Dennison Conroy, MD 16205 Baywood Ln, Granger, IN 46530-7896 Ph: (574) 271-0244 | Michael Dennison Conroy, MD 16205 Baywood Ln, Granger, IN 46530-7896 Ph: (574) 271-0244 |
News Archive
The Center for Global Health Policy's "Science Speaks" blog on Wednesday published a series of posts on the 20th Conference on Retroviruses and Opportunistic Infections (CROI), which took place in Atlanta, Georgia, from Sunday to Wednesday.
UCB announced today that the U.S. Food and Drug Administration (FDA) has approved Keppra (levetiracetam) tablets and oral solution as adjunctive therapy in the treatment of partial onset seizures in adults and children one month of age and older with epilepsy.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that the first patient has been treated in a Phase 1/2 clinical trial of JX-594 in patients with metastatic colorectal cancer who have become refractory to chemotherapy and are either refractory to or ineligible for cetuximab.
BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, is pleased today to announce positive preliminary results in its LIP phase III pivotal study (Lauriad® Immunocompetent Patients Study ). This multicenter randomized, double-blind, placebo controlled study compared the efficacy and safety of a single dose acyclovir Lauriad® 50mg Mucoadhesive Buccal Tablet (MBT) versus matching placebo in patients suffering from recurrent oro-facial herpes.
› Verified 5 days ago
Dr. Leah Napolitano, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12563 State Rd 23, Granger, IN 46530 Phone: 574-335-8300 Fax: 574-335-0775 | |
Dr. Christopher J Quinn, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 52500 Fir Rd, Granger, IN 46530 Phone: 574-271-0700 Fax: 574-273-5648 | |
Dr. Joseph H Cerbin, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 52500 Fir Rd, Granger, IN 46530 Phone: 574-271-0700 Fax: 574-273-5648 | |
Dr. Justin Reed, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 52500 Fir Rd, Granger, IN 46530 Phone: 574-271-0700 | |
Dr. David Charles Grellmann, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6913 N Main St, Granger, IN 46530 Phone: 574-647-1500 Fax: 574-243-4306 | |
Dr. Scott Michael Eshowsky, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6913 N Main St Ste 300, Granger, IN 46530 Phone: 574-647-1500 Fax: 574-647-2567 |